BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 84470)

  • 21. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour stage of mycosis fungoides treated with bleomycin and methotrexate: report from the Scandinavian mycosis fungoides study group.
    Groth O; Molin L; Thomsen K
    Acta Derm Venereol; 1979; 59(1):59-63. PubMed ID: 84469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Molin L; Volden G; Lange Wantzin G; Hellbe L
    Acta Derm Venereol; 1984; 64(6):563-6. PubMed ID: 6084938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical carmustine (BCNU) for patch/plaque mycosis fungoides.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):202-6. PubMed ID: 7986689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hallberg O; Hellbe L
    Acta Derm Venereol; 1979; 59(1):84-7. PubMed ID: 84480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L
    Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to induce tolerance to mechlorethamine hydrochloride.
    Leshaw S; Simon RS; Bear RL
    Arch Dermatol; 1977 Oct; 113(10):1406-8. PubMed ID: 911169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
    Lindahl LM; Fenger-Gron M; Iversen L
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):163-8. PubMed ID: 22229501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
    Kim YH; Martinez G; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contact urticaria and anaphylactic reactions induced by topical application of nitrogen mustard].
    Sánchez Yus E; Surárez Martín E
    Actas Dermosifiliogr; 1977; 68(12):39-44. PubMed ID: 140594
    [No Abstract]   [Full Text] [Related]  

  • 32. Scandinavian mycosis fungoides trial.
    Thomsen K
    Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
    [No Abstract]   [Full Text] [Related]  

  • 33. [Topical chemotherapy in mycosis fungoides (author's transl)].
    Touraine R; Revuz J
    Dermatologica; 1978; 157(6):397-406. PubMed ID: 363476
    [No Abstract]   [Full Text] [Related]  

  • 34. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
    du Vivier A; Vollum DI
    Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical chemotherapy in mycosis fungoides.
    Grupper C; Durepaire R
    Bull Cancer; 1977; 64(2):323-34. PubMed ID: 912134
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
    Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
    Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small malignant melanoma in patients with mycosis fungoides.
    Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
    Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
    Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
    Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
    Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.